Podcasts about Cancer vaccine

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. First, let's delve into the innovative work being done by Grove Biopharma. Founded in 2020 in Chicago, this company is at the forefront of developing polymer-peptide hybrids to target intracellular protein-protein interactions, areas traditionally deemed undruggable. These interactions are crucial regulatory components in numerous cellular processes and are implicated in diseases like cancer and neurodegenerative disorders. However, their smooth protein surfaces present a challenge for traditional small molecule drugs, which struggle to find suitable binding pockets. Similarly, biologics like antibodies and peptides, despite their high binding affinities, face difficulties penetrating cell membranes due to their size and instability. Grove Biopharma addresses these issues through its proprietary Bionics Biologics™ technology. Developed by Nathan Gianneschi at Northwestern University, this approach uses protein-like polymers to mimic proteins with enhanced stability and cellular penetration. These polymers, adorned with peptide branches via living polymerization, maintain peptide binding properties while overcoming previous limitations in drug delivery. This breakthrough has already shown promise in preclinical studies. A 2023 study in Science Advances revealed the efficacy of targeting membrane protein CD36 for treating macular degeneration in mice, while a 2024 study demonstrated PLPs' ability to penetrate neurons and target mitochondria in Huntington's disease models. Moreover, a 2026 Nature Communications publication introduced HYDRAC, a new PLP class capable of degrading MYC and KRAS proteins, reducing tumor growth in mice. Grove Biopharma's pipeline is robust, targeting key areas in cancer and neurodegeneration. Despite challenges typical of the biotech landscape—such as toxicity concerns during clinical trials and scalability issues—Grove's unique platform offers the flexibility needed to address multiple targets effectively. Shifting focus to industry-wide developments, recent advancements highlight significant strides in personalized medicine. Moderna and Merck's mRNA cancer vaccine has shown promising results in a phase 3 study, marking an important step forward for customized healthcare approaches based on genetic profiles. This not only offers hope for cancer treatment but also signifies a wider shift towards more tailored therapeutic strategies. Regulatory updates also play a critical role in shaping industry dynamics. The appointment of Dr. Angelo De Claro as chief of the FDA Oncology Center of Excellence is pivotal. His focus on modernizing regulatory practices aims to expedite drug approvals while ensuring that innovative treatments reach patients more swiftly. However, the FDA's decision to delay approval for Exelixis' tyrosine kinase inhibitor with Roche's Tecentriq underscores the complexities involved in novel therapies' assessments. On the geographical front, Singapore's launch of a biotech hub in Boston highlights the global nature of biotech development. This move strengthens historical ties and emphasizes international collaboration's importance in accelerating scientific research. In clinical trials, AbbVie's success with Qulipta (atogepant) for menstrual migraine prevention is noteworthy. It not only expands therapeutic options for women but also underscores a growing focus on gender-specific health issues within clinical research. Meanwhile, new RAS-targeting therapies continue to emerge as Revolution Medicines' Rasonque gains approval for advanced pancreatic cancer treatment—a significant milestone in addressing previously undruggable mutations. Industry dynamics are further illustrated by leadership changes at major firms like Takeda. The departure of long-time R&D chief Andy Plump often signals strategic shifts that could influence research priorities and corporate focus. Novartis recently faced setbacks with late-stage asset failures impacting its market position and raising investor concerns about its strategic direction concerning mergers and acquisitions. On a similar note, Takeda undergoes organizational changes amid potential strategic shifts following its CEO appointment—demonstrating volatility within companies striving for competitive advantage through effective leadership. Promising developments at the FDA include solidifying leadership with Karim Mikhail at CBER and Michael Davis at CDER—crucial appointments ensuring operational stability amidst past disruptions under former commissioner Marty Makary—and appointing Jared Seehafer as deputy commissioner focusing on AI integration into regulatory processes. Significant financial movements continue highlighting investor interest: Frazier adds over $1 billion targeting small-mid-sized biotech firms while Samsung Biologics secures manufacturing deals emphasizing strategic partnerships' importance globally. Scientific developments also reveal challenges; Silence Therapeutics maintains polycythemia vera leadership despite emerging hurdles while Novo Nordisk halts heart disease studies reflecting complexities validating interleukin-6 as therapeutic targets. AI integration gains momentum transforming operational efficiencies across various functions from R&D to human resources optimizing overall effectiveness within life sciences organizations—a trend poised to reshape people strategy profoundly impacting medical affairs evidenced evaluations enhancing decision-making processes ultimately improving patient outcomes significantly moving forward amidst this dynamic industry landscape filled with opportunities and risks requiring agility and forward-thinking strategies to capitalize on emerging scenarios efficiently and effectively ensuring continued success thriving amidst transformations occurring rapidly around us today, tomorrow, and beyond!Support the show

For the first time in history, a personalized mRNA cancer vaccine has passed a Phase 3 clinical trial. Robert Lufkin MD breaks down the Moderna/Merck melanoma result, how a vaccine custom-built from your own tumor actually works, the 49% drop in recurrence risk behind the headlines — and the honest answer to whether mRNA vaccines will cure cancer. In this episode of Health Longevity Secrets, Robert Lufkin MD explains the science of personalized mRNA cancer vaccines: neoantigens, the AI-designed "most wanted poster" for your immune system, the five-year KEYNOTE-942 data, the stunning pancreatic cancer signal from Memorial Sloan Kettering, the BioNTech colorectal trial shutdown that reminds us why we run trials — and what still sits upstream of it all: your metabolic health. Chapters: 00:00 — Introduction: A Cancer Vaccine Makes History 00:43 — What Just Happened: Moderna/Merck Phase 3 Melanoma Trial 01:44 — A Vaccine Made From Your Own Tumor: How It Works 02:31 — Neoantigens: A "Most Wanted Poster" for Your T-Cells 03:17 — The Numbers Behind the Hype: 49% Lower Recurrence at 5 Years 03:53 — Pancreatic Cancer Vaccine: The Sloan Kettering Survival Signal 04:44 — So Will mRNA Vaccines Cure Cancer? The Honest Answer 05:40 — The Platform Play: Lung, Kidney & Prostate Cancer Trials 06:09 — The Honest Caveats: Press Releases vs Peer Review 06:45 — The Colorectal Trial Shutdown: A Reality Check 07:57 — The Takeaway: Metabolic Health Still Sits Upstream Key takeaways: Intismeran autogene + Keytruda is the first mRNA cancer vaccine to succeed in a Phase 3 trial — FDA approval possibly by early 2027. These are NOT prevention shots — each dose is custom-built from one patient's tumor mutations to hunt residual cancer cells after surgery. Five-year Phase 2b data (KEYNOTE-942): 49% lower risk of recurrence or death, and 62% lower risk of distant metastasis or death at three years. Pancreatic trial (n=16): ~90% of immune responders alive 4–6 years after surgery vs ~25% of non-responders — hypothesis-generating, not proof. The reality check: BioNTech/Genentech halted a colorectal Phase 2 after MORE deaths in the vaccine-alone arm — same technology, different cancer, opposite result. The Phase 3 result is a top-line press release, not yet peer-reviewed; the vaccine is not FDA-approved and is only available in clinical trials today. Muscle, blood sugar control, sleep, not smoking, and sun protection remain the most proven cancer-risk tools you own right now. Studies & sources: Merck/Moderna press release (Aug 19, 2026) — Phase 3 INTerpath-001: intismeran autogene + Keytruda met RFS & DMFS endpoints Nature news — Personalized Moderna/Merck mRNA vaccine reduces melanoma recurrence in Phase 3 Weber et al., J Clin Oncol 2026 — 5-Year Update of KEYNOTE-942 (49% recurrence/death reduction) Rojas et al., Nature 2023 — Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer (MSK) BioNTech statement (Aug 28, 2026) — Phase 2 colorectal trial of autogene cevumeran terminated ABC News — Personalized mRNA cancer vaccine shows promise Dr. Lufkin's book Lies I Taught in Medical School — more at robertlufkinmd.com and the Health Longevity Brief on Substack. ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck's individualized treatment for melanoma, after more than a decade of work on personalized cancer vaccines. Stéphane explains how the treatment works by sequencing an individual patient's tumor and healthy cells, identifying the mutations most relevant to their cancer, and encoding up to 34 of them into an mRNA designed specifically for that patient. Rather than simply unleashing the immune system, the goal is to teach it exactly what to recognize and attack. They also unpack the engineering challenge of manufacturing a different medicine for every patient, how Moderna has brought the process down to roughly 42 days from biopsy to treatment, and what it would take to manufacture personalized medicines at scale. Finally, Stéphane looks beyond melanoma to lung, kidney, bladder, pancreatic, and gastric cancers, as well as Moderna's longer-term work applying mRNA to rare genetic and autoimmune diseases. Resources: Follow Stéphane Bancel on LinkedIn: https://www.linkedin.com/in/st%C3%A9phane-bancel-8185251/ Follow Jorge Conde on X: https://x.com/JorgeCondeBio Stay Updated:Find a16z on YouTube: YouTubeFind a16z on XFind a16z on LinkedInListen to the a16z Show on SpotifyListen to the a16z Show on Apple PodcastsFollow our host: https://twitter.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A new personalised vaccine given in combination with a drug has stopped skin cancer returning in patients during a trial, representing a potentially watershed moment in cancer treatment. Scientists used mRNA technology, which was used for some Covid-19 vaccines.But that technology - and vaccines more generally - have become increasingly controversial in the United States since the Covid-19 pandemic. The Health Secretary Robert F Kennedy Jr, is a vaccine sceptic. In August 2025 cancelled $500m (£376m) in funding for mRNA vaccine research. The move impacted 22 projects being led by major pharmaceutical companies, including Pfizer and Moderna, for vaccines against bird flu and other viruses, according to Kennedy's department. We speak to Tom Whipple, host of the BBC's Inside Science programme, about the science of this new vaccine. And we ask how funding cuts for vaccine research could impact health outcomes not just for Americans, but for the world.For more episodes, just search 'The Global Story' wherever you get your BBC Podcasts.

(0:00) Bestie intros: Recapping recent interviews and the state of American science (3:31) China's Robot Olympics, Optimus update, Grok Bot (9:05) Nvidia and Salesforce rip after big earnings: AI Capex Bubble and SaaSpocalypse narratives get reversed (33:32) Bessent gets called out by Druckenmiller for bond market interference (1:01:33) AI writing controversy: Druck used AI to write his WSJ Op-ed (1:15:00) CIA Chief visits Moscow, Meta's settlement and new teen rules (1:22:52) Science Corner: Moderna's mRNA cancer vaccine Come hang with the Besties at the All-In Summit | September 13-15: http://theallinsummit.com Follow the besties: https://x.com/chamath https://x.com/Jason https://x.com/DavidSacks https://x.com/friedberg Follow on X: https://x.com/theallinpod Follow on Instagram: https://www.instagram.com/theallinpod Follow on TikTok: https://www.tiktok.com/@allin Follow on LinkedIn: https://www.linkedin.com/company/allinpod Intro Music Credit: https://rb.gy/tppkzl https://x.com/yung_spielburg Intro Video Credit: https://x.com/TheZachEffect Referenced in the show: https://www.cnbc.com/2026/08/27/nvidia-nvda-q2-earnings.html https://finance.yahoo.com/markets/stocks/article/how-nvidia-silenced-the-bears-105017893.html https://nvidianews.nvidia.com/news/nvidia-announces-financial-results-for-second-quarter-fiscal-2027 https://polymarket.com/event/largest-company-end-of-december-2026 https://www.cnbc.com/2026/08/18/treasury-yields-.html https://www.cnbc.com/2026/08/24/bessent-1-trillion-treasury-general-account-bond-buybacks.html https://seekingalpha.com/news/4636322-wall-street-sees-bessent-putting-fear-of-god-into-bond-vigilantes https://www.wsj.com/opinion/let-the-bond-market-speak-81529d74 https://www.wsj.com/world/cia-director-john-ratcliffe-makes-surprise-trip-to-moscow-c1c68fa6 https://polymarket.com/event/russia-x-ukraine-ceasefire-agreement-by

For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma from returning in high-risk patients, sending drug industry stocks soaring. WSJ's Xavier Martinez traces Moderna's wild ride from scrappy startup to the frontier of can treatment. Ryan Knutson hosts. Further Listening: - The FDA Commissioner on Vaccines and Public Trust - The Creator of the Record-Setting Covid Vaccine Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send Zorba a message!Zorba's thoughts on the groundbreaking mRNA therapeutic vaccine to combat melanoma.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

Send Zorba a message!Zorba's thoughts on the groundbreaking mRNA therapeutic vaccine to combat melanoma.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

Personalised vaccines could offer a breakthrough in the fight against cancer. Our correspondent analyses the latest trial. Canada's oil market is flourishing, despite the trade war. And, why we will always love Dolly Parton.Guests and host:Natasha Loder, health editorSarah Lawrynuik, deputy editor of “The Intelligence”Jon Fasman, senior culture correspondentJason Palmer, co-host of “The Intelligence”Topics covered: Cancer, immunotherapy, vaccines, mRNAOil, Canada, trade war, tariffsDolly Parton, country musicListen to what matters most, from global politics and business to science and technology—subscribe to The Economist. Hosted on Acast. See acast.com/privacy for more information.

Personalised vaccines could offer a breakthrough in the fight against cancer. Our correspondent analyses the latest trial. Canada's oil market is flourishing, despite the trade war. And, why we will always love Dolly Parton.Guests and host:Natasha Loder, health editorSarah Lawrynuik, deputy editor of “The Intelligence”Jon Fasman, senior culture correspondentJason Palmer, co-host of “The Intelligence”Topics covered: Cancer, immunotherapy, vaccines, mRNAOil, Canada, trade war, tariffsDolly Parton, country musicListen to what matters most, from global politics and business to science and technology—subscribe to The Economist. Hosted on Acast. See acast.com/privacy for more information.

First, we speak to The Indian Express' Purnima Sah about Maharashtra's new anti-conversion law, why Christian congregations are asking worshippers to sign self-declaration forms, and the concerns surrounding disruptions and monitoring of prayer meetings.ext, we speak to The Indian Express' Anonna Dutt about Intismeran, a personalised cancer vaccine that has shown promising results against skin cancer, how it works alongside immunotherapy, and whether similar treatments could eventually become accessible in India. (12:50)And in the end, we look at Cricket Australia's decision to allow former Mumbai Under-19 cricketer Anaya Bangar to play women's community cricket following her gender transition, and the different eligibility rules governing transgender participation at the community and elite levels. (23:35)Hosted by Ichha SharmaProduced and written by Shashank Bhargava, Niharika Nanda and Ichha SharmaEdited and mixed by Suresh Pawar

P.M. Edition for Aug. 26. Tech reporter Meghan Bobrowsky tells us why the Meta settlement could change how teenagers use some of the world's most popular apps. Plus, the FDA approves a milestone therapy for pancreatic cancer. WSJ reporter Xavier Martinez discusses how the nearly $40,000-a-month drug from Revolution Medicines could change patient outcomes of one the deadliest cancers. And the FBI shuts down a sprawling hacking network linked to China that targeted NASA, the Federal Reserve and critical infrastructure. Sabrina Siddiqui hosts. Sign up for the WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of The Brainstorm, Sam, Nick, and Brett break down Merck and Moderna's positive Phase 3 results for a personalized mRNA cancer vaccine, a treatment custom-built from each patient's own tumor that cut mortality from advanced melanoma by roughly 50% versus the standard of care. The team digs into cost, manufacturing scale, and why the capital poured into mRNA during COVID may be paying off in oncology. Then Brett reports back from a weekend with Grok Bot, which recovered $75 of his wife's forgotten escrow money on its first task, and the team debates why multiplayer agents could be the real threat to Microsoft's enterprise moat.Key Points From This Episode:How a custom mRNA vaccine trains the immune system against a patient's own tumor, and what Phase 3 melanoma results could mean for other cancersWhy $200K–$300K per treatment limits early use, and what we believe has to change for personalized oncology to scaleWhy agents that live inside team chat, not one-on-one, may be the real disruption to Microsoft and SlackIf you know ARK, you know we focus on long-term innovation. But that doesn't mean we ignore breaking news. Every day, we debate the latest developments in tech and markets. Now, we're bringing those conversations to you in “The Brainstorm,” a co-production from ARK, WOLF, and Public. Tune in weekly for our quick takes on what's shaping innovation right now.Learn more about WOLF: https://wolf.financialLearn more about Public: https://public.com/Disclosure: http://arkinv.st/39rzF94

Mike talks with Dr. Mike Roizen about the cancer vaccine and more of the latest health and wellness news.

A personalised mRNA vaccine has shown promising early results in preventing high-risk melanoma from returning when combined with the immunotherapy drug Keytruda. Dr Heidi Hart explains how the treatment works, why the trial results are significant, and what still needs to happen before personalised cancer vaccines could become widely available. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Scientists have used AI to find a possible cure for skin cancer. Why do so many people polled say they won't take it? Bruce and Gaydos discuss.

A new personalised vaccine given in combination with a drug has stopped skin cancer returning in patients during a trial, representing a potentially watershed moment in cancer treatment. Scientists used mRNA technology, which was used for some Covid-19 vaccines.But that technology - and vaccines more generally - have become increasingly controversial in the United States since the Covid-19 pandemic. The Health Secretary Robert F Kennedy Jr, is a vaccine sceptic. In August 2025 cancelled $500m (£376m) in funding for mRNA vaccine research. The move impacted 22 projects being led by major pharmaceutical companies, including Pfizer and Moderna, for vaccines against bird flu and other viruses, according to Kennedy's department. We speak to Tom Whipple, host of the BBC's Inside Science programme, about the science of this new vaccine. And we ask how funding cuts for vaccine research could impact health outcomes not just for Americans, but for the world.Producers: Lucy Pawle and Sam ChantarasakDigital producer: Sam GruetMix: Travis EvansEditor: James ShieldSenior news editor: China CollinsPhoto: US Secretary of Health and Human Services Robert F. Kennedy Jr. testifies during the Senate Finance Committee's hearing on The President's Health Care Agenda on Capitol Hill in Washington, DC, USA, 04 September 2025. Credit: Shawn Thew/EPA/Shutterstock

August 25, 2026 ~ Emergency medicine physician Dr. Frank McGeorge joined the show to discuss how artificial intelligence is accelerating cancer vaccine research, helping scientists develop more targeted treatments and potentially changing the future of cancer care. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Infosec Decoded Season 6 #56: Cancer VaccineWith sambowne@infosec.exchange and Doug SpindlerLinks: https://samsclass.info/news/news_082526.htmlRecorded Tue, Aug 25, 2026

P.M. Edition for Aug. 24. Treasury Secretary Scott Bessent says the U.S. will go after countries and companies that do business with Iran. White House economic policy reporter Brian Schwartz says it's unclear what will happen with Iran's top trading partner: China. Plus, President Trump escalates the trade conflict with Canada, threatening 50% tariffs on autos. And Heard on the Street columnist David Wainer discusses the challenges Moderna faces in fulfilling investor hopes for a sweeping new era for cancer treatment. Pierre Bienaimé hosts. The AI Therapist: A WSJ Podcast Series  Sign up for the WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Pour Over is a Christ-first, politically neutral news podcast. Every Monday, Wednesday, and Friday, we cover the day's biggest stories in ~10 minutes, and pair the biggest headlines with brief biblical reminders. Looking to support us? You can choose to pay ⁠here⁠. On today's episode: National Debt Tops $40T Cancer Vaccine Shows Promising Results U.S. Threatens Economic Pressure on Iran Florida Finishes Primaries Lindsay Clancy Case Nearing Conclusion U.S. & South Korea Cut Military Drills Short NIH Adviser Pleads Guilty to Concealing COVID Records Prince Harry and Family Plan Return to London Thanks to our sponsors: The Voice of the Martyrs: Give a Village Outreach Kit | vom.org/TPO Wild Alaskan: $35 off your first box | code: TPO Quince: Free shipping | quince.com/tpo AdelFi: Apply for the Harvest Bundle | https://adelfibanking.com/pourover Upside: extra 25 cents back for every gallon on your first tank of gas | code: TPO LMNT: free 8-pack with purchase | https://links.thepourover.org/LMNT_Podcast Mosh: 25% off first variety pack + 20% off subscription | code: TPO25 Serving Orphans Worldwide: Give a gift to feed a child for a month | https://servingorphans.org/thepourover MORE FROM TPO: ⁠Free newsletter⁠ ⁠Watch TPO on YouTube⁠ ⁠Download the TPO App⁠ Unless otherwise noted, all scripture references are from the Christian Standard Bible (CSB) translation. Learn more about your ad choices. Visit megaphone.fm/adchoices

Moderna stock surged over 160% after their personalized mRNA cancer vaccine intismeran, combined with Merck's Keytruda, reported a successful trial for melanoma. But after the COVID-19 vaccine debacle, can mRNA technology be trusted? Salty Cracker joins Dr. Drew LIVE to discuss the new mRNA cancer treatment, ex Dr. Fauci adviser David Morens pleading guilty to conspiracy, the now-over-$900k GoFundMe for accused murderer Lindsay Clancy (allegedly benefiting her parents), and Roysha / Royce White's WNBA draft bid. Salty Cracker is an uncensored clown world commentator known for breaking the Left with satire, shame, and ridicule. He is active on Rumble as TheSaltyCracker. Follow at https://x.com/saltycracker9 「 SUPPORT OUR SPONSORS 」 • BIOPRO - BioPro+® is a natural formula of growth factors and peptides that support how you look, feel & perform. Learn more at ⁠⁠⁠https://drdrew.com/biopro⁠⁠⁠ • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • CHAPTER - For free and unbiased Medicare help, dial (218) 521-2472 to speak with my trusted partner, Chapter, or go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://askchapter.org/drdrew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapter and its affiliates are not connected with or endorsed by any government entity or the federal Medicare program. Chapter Advisory, LLC represents Medicare Advantage HMO, PPO, and PFFS organizations and stand alone prescription drug plans that have a Medicare contract. Enrollment depends on the plan's contract renewal. While we have a database of every Medicare plan nationwide and can help you to search among all plans, we have contracts with many but not all plans. As a result, we do not offer every plan available in your area. Currently we represent 50 organizations which offer 18,160 products nationwide. We search and recommend all plans, even those we don't directly offer. You can contact a licensed Chapter agent to find out the number of products available in your specific area. Please contact Medicare.gov, 1-800-Medicare, or your local State Health Insurance Program (SHIP) to get information on all of your options. 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Jordan and Nate pre record this one but still pack in plenty, starting with RFK's ongoing Real Food Show and a genuinely fascinating podcast episode with a very deaf Lou Ferrigno on ditching diet culture for good. From there they dig into Trump's pick for FDA commissioner, Dr. Heidi Overton, and why her ties to the recent childhood vaccine executive order have some old guard MAHA voices nervous. The big one this week is Fauci's longtime NIAID advisor pleading guilty to a federal conspiracy involving hidden COVID records, with ties back to Eco Health Alliance and the gain of function money trail. They also break down a new FDA rule closing a decades old food safety loophole, debate a splashy Moderna and Merck mRNA cancer vaccine, and wrap with a genuinely thoughtful conversation about the federal roadless rule and what it means for wildfire management out west. Equal parts hard news and honest back and forth between friends.

Our Fear Of Missing Out report this week starts out with politicians trying to use God to get votes. Dr. Fauci's top advisor pleads guilty and some live entertainers got a lot of COVID money that they might have to pay back. Two people you would probably know just got baptized and we might now have a new vaccine for cancer.

Oceanbird Wing Sail InstallationSource: Interesting Engineeringhttps://interestingengineering.com/videos/giant-150-foot-wing-just-set-sail-on-a-754-foot-cargo-ship-and-it-runs-on-windhttps://www.theoceanbird.com/press-releases/oceanbird-completes-installationQuaise Energy Superhot Geothermal PlantSource: ESG Today / Fast Companyhttps://www.esgtoday.com/quaise-energy-raises-134-million-to-build-first-ever-superhot-geothermal-power-plant/https://www.fastcompany.com/91572753/this-houston-geothermal-startup-is-betting-it-can-beat-fossil-fuels-on-costhttps://quaiseprojectobsidian.com/AI-Driven Optical TweezersSource: Phys.org / Naturehttps://phys.org/news/2026-06-ai-driven-optical-tweezers-hundreds.htmlhttps://www.nature.com/articles/s41592-026-03129-3Moderna and Merck Melanoma Vaccine TrialSource: Reutershttps://www.reuters.com/legal/litigation/merck-moderna-say-melanoma-skin-cancer-vaccine-meets-goals-large-trial-2026-08-19/Solar-Powered Plastic RecyclingSource: University of Cambridge / Naturehttps://www.cam.ac.uk/research/news/scientists-demonstrate-solar-powered-plastic-recycling-at-real-world-scalehttps://www.nature.com/articles/s44286-026-00406-yCopper Drug for Alzheimer's TreatmentSource: Monash University / ACS Chemical Neurosciencehttps://www.monash.edu/news/articles/copper-drug-restores-memory-and-clears-toxic-alzheimers-proteins

Hey this is Alex, welcome to... the chillest week in AI, since ... a long time. Chill, if you consider Moderna and MERK announcing a cancer vaccine and surging 115% in a day, a chill week. This week, the only two model drops we really saw came from the excellent Z.ai folks, they announced GLM 5.3, API only for now, and an amazing tiny release of Qwen 3.89 27B. In other big AI news, OpenAI announced they are pausing RL efforts (Reinforcement Learning) to focus on security and alignment post the scary AI Swarms hacking incident, dedicating up to 20% of compute towards reviewing agent thinking processes, and Stripe buying OpenRouter for a reported $8B! Sometimes the chill weeks are actually good, we're able to chat about how we use AI, what changed for us, and give our guests a bit of breathing room. This week, I invited Francesco from CUA to talk about computer use in open source + their new history plugin, Bin from HeyGen to talk about HyperFrames, a way for your agents to create videos and a breaking news guest, Jeff Huber from Chroma jumped on to talk about their new Foundations release, a unified memory for your agents! This was a great episode, I hope you'll like it, it's up here on Substack and everywhere you get your pod (Spotify, Youtube, Apple Podcasts). ThursdAI - Highest signal weekly AI news show is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.Are we being fed slop again? (Is Claude dumb again?)Before we get to releases, this week on the show, I complained, again, that I feel my AI's are degrading. If this feels like de-ja-vu to you, it's because the same happened a year ago in September 2025 (and Anthropic admitting this 2 weeks later), and ... now this happens with Fable?You see, I use pretty much the same prompts, every week, preparing for the show. This is partly my way to evaluate new models and compare to existing and previous ones while also bringing you the best researched weekly show in AI. Well, this week, one after another, Claude Fable, which is... like the best intelligence, gave me such poor output, that I couldn't believe what I'm seeing. First, literally ignoring instructions that say “hey, show me all the items I've collected and let me pick the most important ones”, Fable instead sent all of them to my research pipeline, without showing me. This has worked, consistently, without fail, for the past... year? maybe more! This worked with open source models, worked with GPT, and now Fable, a Mythos Level LLM, is doing the most basic dumb s**t possible, ignoring the main reason I even have this workflow. And this wasn't just a fluke either, when asked to create a run of show document, and given an example, Fable produced this... whatever this is. This is the same document and same format that Fable produced for me during AI Engineer which got me thinking “ok, this is AGI”, and here, given an example, I got a completely unusable artifact, despite direct instructions, structure and example! I got to say, given that privately this week, Anthropic disclosed that they have passed $65B in revenue, which is absolutely insane, this doesn't add up. So I figured, ok Alex, maybe this is your prompts or skills. But no, LDJ came in with some charts that show degradation, one from MarginLab.ai that shows significant lowering on number of tool calls and average runtime recently (this is for Opus 5) and And another chart from modelverify.ai model drift monitor showing drift scores.Do we have anoher Claude Gate on our hands? Is your Fable/Opus behaving weird lately? Or did you completely switched away to other models? OpenAI pausing RL and focusing on safetyLook, when we covered the HF hacking incident and then the pacing the frontier letter, I didn't imagine that results will come this fast, but this week, OpenAI publicly announced that they are pausing RL training, which is the last step of models, until they get their sandboxes in order and align the models better. We all agreed on stage that this is likely a very good move, and Peter was really awe-struck at the 20% dedication of resources towards reviewing thought processes of models. Is this a good enough response to the scary hacking incident? we'll see, but I think this is the right move from OpenAI, and still, waiting for the full postmortem on the OpenAI security incident. Open Source LLMsQwen3.8-27B ties GPT-5.6 Luna and runs on a 4090 (X, HF, Announcement)Following the release of their flagship, Alibaba dropped a model that became a community darling overnight, Qwen 3.8 with just 27B parameters. This “tiny” model scores 52 on the Artificial Analysis Intelligence Index, same score as GPT 5.6 Luna at Max reasoning and 51 on Agentic index, beating Opus 4.8 MaxAll while running at around 68t/s on a 4090 GPU, and around 40 on max via MLX, hell it even does 11t/s on Xenova's WebGPU kernels right in the browser! This model exploded on the HuggingFace hub, with tons of quants, over 152 fine-tunes, it was downloaded over 10M times overall

BUY CAST BREW COFFEE TO SUPPORT THE SHOW - https://castbrew.com/ Become A Member And Protect Our Work at http://www.timcast.com Host: Tim Pool @Timcast (everywhere) | https://www.shoutout.fans/timpool My Second Channel - https://www.youtube.com/timcastnews Podcast Channel - https://www.youtube.com/TimcastIRL For advertising inquiries please email sponsorships@rumble.com

Drugmakers Merck and Moderna unveil a study claiming an experimental mRNA vaccine reduced recurrence of melanoma. Progressive Democrats surprise analysts with primary wins in Florida. And a former Ukrainian defense minister says Volodymyr Zelenskyy should face a wartime election. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Headlines: – Welcome to Mo News + Tom Holland Workout (02:00) – A New mRNA Vaccine Could Prevent Melanoma From Returning (05:30) – Trump Says He'll Meet North Korea's Kim Jong Un Later This Year (08:50) – U.S. Conducting Stealth Operation To Transport  Oil Through Hormuz (12:30) – Meta Trial: Whistleblower says Zuckerberg Lied About Concern For Child Safety (19:00) – Penn State Fraternity Members Are Charged in Cocaine Trafficking Case (21:30) – Why Factory-Built Homes are Reaching the Suburbs (25:20) – Harry and Meghan Will Move Back to Britain (27:45) – LinkedIn Has Accidentally Become a Dating Site—Despite Its No-Romance Rules (31:30) – On This Day In History (36:30) Thanks To Our Sponsors:  – Monarch - 50% off your first year | Code: MONEWS – Factor - 50% off your first box | Code: monews50off –⁠ Industrious⁠ - Coworking office. 50% off day pass | Code: MONEWS50 – LMNT | Free Sample Pack with any LMNT drink mix or 12oz cans purchase – ⁠Boll & Branch⁠ – 20% off first order, plus free shipping | Code: MONEWS

The news to know for Thursday, August 20, 2026! We'll tell you how the U.S. national debt hit a record $40 trillion and what it could mean for everyday Americans. Also, what we know about President Trump's pick to lead the FDA. And about a new melanoma vaccine that could be on the market as soon as next year. Plus, where some temperatures have broken all-time records, why some U.S. soldiers are being offered time off to play a video game, and how the NFL plans to expand overseas. Those stories and even more news to know in about 15 minutes!    Join us every Mon-Fri for more daily news roundups!  See sources: https://www.theNewsWorthy.com/shownotes Become an INSIDER to get AD-FREE episodes here: https://www.theNewsWorthy.com/insider Get The NewsWorthy MERCH here: https://thenewsworthy.dashery.com/ Sponsors: Sleep cooler this summer with Boll & Branch. Get 15% off your first order plus free shipping at BollAndBranch.com/newsworthy with code newsworthy For a limited time, get 60% off your first order, plus free shipping and free treats for life, when you head to Smalls.com/NEWSWORTHY. To advertise on our podcast, please reach out to ad-sales@libsyn.com 

This week Merck (known as MSD in Europe) and Moderna announced that a personalised cancer vaccine had significantly improved the outcomes of melanoma patients. Is the era of the cancer vaccine, at last, upon us? What does that mean? Anne Willis, a cancer cell biologist at the Medical Research Council, joins us to discuss. In just a few weeks the Royal Society will be putting out the red carpet as the most coveted prize in non-fiction science is about to be awarded. We will be speaking weekly to the shortlisted authors for the Royal Society Trivedi Book Prize, and we are starting with Kit Chapman, author of the Age of Alchemy. Plus, Penny Sarchet has, like an alchemist of old, been scouring the most obscure texts and journals to bring us the latest science knowledge. Presenter: Tom Whipple Producers: Alex Mansfield, Tabitha Taylor Buck, Katie Tomsett, Keiran Manetta-Jones Editor: Ilan Goodman Production Co-ordinator: Jana Bennett-Holesworth

A new skin cancer vaccine helps kill melanoma.See omnystudio.com/listener for privacy information.

Moderna shares soared more than 172% after strong results for its vaccine for melanoma skin cancer. Elsewhere, the Evergrande saga came to a dramatic conclusion in a Shenzhen court. And what will Walmart spend its $3 billion Trump tariffs rebate on?World Business Express - Finance, economy and business news from BBC journalists around the world. The stories that matter: World Business Express brings you the essentials on the fast-changing global economy. What forces are driving the markets and industry? Hear unique insight from top CEOs, investors, economic thinkers and small business bosses.

U.S. government debt tops $40 trillion for the first time, adding to fears of a brewing fiscal crisis. The IDF investigates its own troops over five incidents involving the deaths of Palestinians, including the 2024 killing of 5-year-old Hind Rajab in Gaza. A cancer vaccine for melanoma sparks hope of treatment for a variety of tumors. And humanoid robots show off their every day skills at the World Robot Conference.

Neuroscientist and educator Jared Cooney Horvath testified before the Senate earlier this year on the impacts of classroom technology. Horvath shares his thoughts on screen time and education.Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients. Dr. Jon LaPook and trial researcher Dr. Janice Mehnert have more information.Neuroscientist and educator Jared Cooney Horvath testified before the Senate earlier this year on the impacts of classroom technology. Horvath shares his thoughts on screen time and education.For America's 250th birthday, USAA unveiled The National Military Monument in Washington, D.C., a living tribute to the more than 41 million veterans who have served the U.S. USAA Senior Vice President Rob Braggs shares that the monument will stay open through Nov. 12. Visit https://monument250.usaa360.com/ for more information. (Sponsored by USAA)Students nationwide are grappling with a new reality -- AI-generated pornography, sometimes featuring themselves or someone they know. CBS News found more than a dozen AI "nudify" apps easily accessible in app stores, some without age restrictions. Jo Ling Kent has more.The NFL is launching a new "celly" campaign to honor the tradition of touchdown celebration dances in the end zone. Jason Allen joins the Houston Texans at their training facility to learn more.

FIND MORE from Nicolas Hulscher, MPH HERE: https://nicolashulscher.com/ Substack: https://www.thefocalpoints.com/ X: https://x.com/NicHulscher GET CHLORINE DIOXIDE SOLUTIONS HERE: https://frontierpharm.com?sca_ref=11953077.06TP4RWJ73 Use code WAM to save on your order! GET YOUR APRICOT SEEDS at the life-saving Richardson Nutritional Center HERE: https://rncstore.com/r?id=bg8qc1 Use code JOSH to save money! Pledge here! Just a dollar a month can help keep us alive! https://www.patreon.com/user?u=2652072&ty=h&u=2652072 EXCLUSIVE replays of hour plus long live shows are available here at $5 a month or more! HELP SUPPORT US AS WE DOCUMENT HISTORY HERE: https://gogetfunding.com/help-keep-wam-alive/# Josh Sigurdson talks with epidemiologist Nicolas Hulscher who is also an administrator at the McCullough Foundation about the dangers of the childhood vaccine schedule as a historic number of parents are questioning the safety surrounding childhood injections. Hulscher who has gone viral recently for his brave stance against Big Pharma as an epidemiologist has published countless papers cited by many. In this video, we delve into the issue of the childhood vaccine schedule, the effects of vaccines on development, illness and neurological conditions such as autism. We also talk about the dangers of mRNA, the new mRNA cancer vaccine, the new mRNA flu shots and of course real alternatives for cancer treatment from Ivermectin to laetrile and Vitamin C IVs. Are flu shots causing severe auto-immune disorders? What is the proof? Of course, a question many people are asking is, "Is MAHA dead?" Hulscher is pretty upfront about how he feels about the movement as we see fast-tracking of mRNA injections, approval of mRNA vaccines for 6 month olds, the push for Measles vaccines, the new CDC Chair, the approval of glyphosate without cancer warnings and much more. This is a very insightful interview and we urge everyone to watch and take notes! Stay tuned for more from WAM! GET HEIRLOOM SEEDS & NON GMO SURVIVAL FOOD HERE: https://heavensharvest.com/wam USE Code WAM to save 25% plus free shipping! USE Code WAM50 for 50% off on select items like the #10 cans & MRE packs! BUY GOLD HERE: https://firstnationalbullion.com/schedule-consult/ Avoid CBDCs! GET 10% OFF ON SHILAJIT FROM DR. KAUFMAN WHEN YOU USE CODE WAM10 HERE: https://medauthentica.com/discount/WAM10?redirect=/products/authentica-shilajit%3Fsca_ref=10867124.wrNV3jkYSaMg9 GET YOUR WAV WATCH HERE: https://buy.wavwatch.com/WAM Use Code WAM to save $100 and purchase amazing healing frequency technology! Get Your SUPER-SUPPLIMENTS HERE: https://vni.life/wam Use Code WAM15 & Save 15%! Life changing formulas you can't find anywhere else! Get local, healthy, pasture raised meat delivered to your door here: https://wildpastures.com/promos/save-20-for-life/bonus15?oid=6&affid=321 USE THE LINK & get 20% off for life and $15 off your first box! DITCH YOUR DOCTOR! https://www.livelongerformula.com/wam Get a natural health practitioner and work with Christian Yordanov! Mention WAM and get a FREE masterclass! You will ALSO get a FREE metabolic function assessment! PayPal: ancientwonderstelevision@gmail.com FIND OUR CoinTree page here: https://cointr.ee/joshsigurdson PURCHASE MERECHANDISE HERE: https://world-alternative-media.creator-spring.com/ JOIN US on SubscribeStar here: https://www.subscribestar.com/world-alternative-media For subscriber only content! BITCOIN ADDRESS: 18d1WEnYYhBRgZVbeyLr6UfiJhrQygcgNU World Alternative Media 2026

Digital Content Editor, Barbara Friedman, shared her top three stories trending online. Views and News with Clarence Ford is the mid-morning show on CapeTalk. This 3-hour-long programme shares and reflects a broad array of perspectives. It is inspirational, passionate and positive. Host Clarence Ford’s gentle curiosity and dapper demeanour leave listeners feeling motivated and empowered. Known for his love of jazz and golf, Clarrie covers a range of themes including relationships, heritage and philosophy. Popular segments include Barbs’ Wire at 9:30 am (Mon-Thurs) and The Naked Scientist at 9:30 on Fridays. Thank you for listening to a podcast from Views & News with Clarence Ford Listen live on Primedia+ weekdays between 09:00 and 12:00 (SA Time) to Views and News with Clarence Ford broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/erjiQj2 or find all the catch-up podcasts here https://buff.ly/BdpaXRn Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

President Donald Trump weighs in on the potential for US-Iran peace talks as regional tensions widen. We have the latest congressional lawmaker facing an ethics investigation. We'll tell you about a big change in the Texas track meet stabbing case ahead of the defendant's hearing for a new trial. A win for cancer research is being felt on Wall Street. Plus, the president shows off his latest White House makeover projects. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Plus: Target's second-quarter sales suggest the retailer's turnaround is working. And Cantor Fitzgerald plans to give its hedge-fund clients access to Kalshi's prediction markets. Alex Ossola hosts. Sign up for WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Elizabeth Burton, Chief Strategist at Fortress Investment Group, assesses the broader investment landscape and where she sees opportunity as investors balance growth against emerging risks. Health care takes center stage as Courtney Breen of Bernstein breaks down developments involving Moderna and Merck and what they mean for biotech and pharmaceutical investors as both stocks soar following promising results in a late-stage trial. Moderna jumped nearly 200%. Lo Toney of Plexo Capital tackles a key question in the AI race: is OpenAI losing momentum? Our Eunice Yoon reports on a Chinese humanoid robotics company going public and what the deal reveals about China's ambitions in robotics and AI. Finally, Kate McShane of Goldman Sachs analyzes the latest retail movers, reacts to Target and previews Walmart earnings as investors search for fresh signals on the health of the consumer. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Trade secrets: There may be a deal between Ottawa and Washington, but it's still not clear what's in it. The U.S. president says American farmers and manufacturers are going to be thrilled with the deal. The prime minister says it secures the best terms for Canada's important sectors. And: As part of talks with Ottawa, U.S. President Donald Trump is pushing for a revival of the Keystone XL oil pipeline. The plan was to take oil from Alberta -- south to Nebraska. Also: A potential vaccine for skin cancer has positive trial resultsPlus: settler violence in the West Bank, calls for Ukrainian elections, and more.

Market update for August 19, 2026Check out the Public app for incredible investing tools and to support the show (LINK)Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.In today's episode, Zaid covers:Why bond yields are surging around the world, and what 5% long-term rates could mean for stocksTrump's last-minute pause on 50% tariffs targeting Canadian goodsTarget's latest earnings and whether its turnaround is actually workingModerna's major personalized cancer vaccine breakthrough and Lowe's disappointing outlookWhy some Gen Z investors are treating sports betting like part of their long-term financial strategy

Dr. John Bassett, a Gastroenterologist, joins It Takes Two with Amy & JJ to discuss a colon cancer vaccine and what this new development means for your health.See omnystudio.com/listener for privacy information.

────────────────────────────────────────[00:02:23]Moderna Launching an mRNA Cancer Vaccine — for Patients Who Already Have Metastatic CancerThe shot caused the cancer explosion; now programming immune-compromised patients to produce tumor proteins; control group gets a different mRNA — no placebo.────────────────────────────────────────[00:10:05]Scientists Warn Moderna's mRNA Cancer Vaccine May Itself Cause Tumor GrowthJessica Rose: undisclosed antigens prevent independent safety assessment; Dr. Hoecker: counterintuitive to promote a therapy that causes cancer; FDA will approve it anyway.────────────────────────────────────────[00:34:38]Whistleblower Doctor: Booster Interval Timed to Hit White Blood Cell Production While DownFirst dose cuts production by 50%; second drops it to 25%; booster carries 81 strands of foreign bacteria the weakened immune system cannot fight.────────────────────────────────────────[00:38:48]Acosta Gave Epstein a Sweetheart Deal Because He Was Told Epstein Was Intelligence — Ken Starr Then Became His Defense AttorneyThe same Starr who gave Clinton a pass became Epstein's lawyer; a victim who refused to speak was forced forward when DOJ published her name.────────────────────────────────────────[00:40:32]Trump Sent Ivanka as a Teenager to Brunel — Modeling Agent Later Convicted of Rape and PedophiliaBrunel trafficked women into debt bondage for Epstein; the Uzbek woman now speaking out was one of his victims; Brunel died in prison in 2022.────────────────────────────────────────[01:14:55]China Cut Oil Consumption to Prevent a Global Depression — Trump Appears to Be Trying to Create OneChinese foreign minister: the Strait was open before the war; US-Israel operations created the crisis; China offset 5% of the 20% lost by cutting its consumption.────────────────────────────────────────[01:21:11]After the Iran War, Both Sides Have Revealed Their Limits — Next Conflict Requires a Domestic TriggerUS and Israel cannot change Tehran by force; Iran cannot inflict critical damage; both will prepare for a conflict requiring something to happen on American soil.────────────────────────────────────────[01:25:07]Hegseth Asks Congress for $1.5 Trillion for a War Trump Already Declared WonSenator to Hegseth: unlimited bomb money while cutting food, healthcare, and farm support; Palmer Luckey is building autonomous Terminator drones with Thiel's money.────────────────────────────────────────[01:52:30]The Covenant With Moses Was Conditional — Israel Broke It and God Destroyed the Nation ForeverPalestine today is a devilish counterfeit; the Old Testament testifies of Christ, not an ethnic group or political state — fundamental error of Christian Zionism.────────────────────────────────────────[01:55:08]Trump Contradicts Himself in the Same Sentence — Desperate to Meet Iran, But Not ReadyIran's missiles change speed mid-flight defeating every US defense system; Trump blamed Jordan attack on Jordanians. ──────────────────────────────────────── Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code “KNIGHT” For high quality made in America products go to HomeSteadProducts.shop and use promo code “Knight” for 10% off your purchases Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-show Or you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

────────────────────────────────────────[00:02:23]Moderna Launching an mRNA Cancer Vaccine — for Patients Who Already Have Metastatic CancerThe shot caused the cancer explosion; now programming immune-compromised patients to produce tumor proteins; control group gets a different mRNA — no placebo.────────────────────────────────────────[00:10:05]Scientists Warn Moderna's mRNA Cancer Vaccine May Itself Cause Tumor GrowthJessica Rose: undisclosed antigens prevent independent safety assessment; Dr. Hoecker: counterintuitive to promote a therapy that causes cancer; FDA will approve it anyway.────────────────────────────────────────[00:34:38]Whistleblower Doctor: Booster Interval Timed to Hit White Blood Cell Production While DownFirst dose cuts production by 50%; second drops it to 25%; booster carries 81 strands of foreign bacteria the weakened immune system cannot fight.────────────────────────────────────────[00:38:48]Acosta Gave Epstein a Sweetheart Deal Because He Was Told Epstein Was Intelligence — Ken Starr Then Became His Defense AttorneyThe same Starr who gave Clinton a pass became Epstein's lawyer; a victim who refused to speak was forced forward when DOJ published her name.────────────────────────────────────────[00:40:32]Trump Sent Ivanka as a Teenager to Brunel — Modeling Agent Later Convicted of Rape and PedophiliaBrunel trafficked women into debt bondage for Epstein; the Uzbek woman now speaking out was one of his victims; Brunel died in prison in 2022.────────────────────────────────────────[01:14:55]China Cut Oil Consumption to Prevent a Global Depression — Trump Appears to Be Trying to Create OneChinese foreign minister: the Strait was open before the war; US-Israel operations created the crisis; China offset 5% of the 20% lost by cutting its consumption.────────────────────────────────────────[01:21:11]After the Iran War, Both Sides Have Revealed Their Limits — Next Conflict Requires a Domestic TriggerUS and Israel cannot change Tehran by force; Iran cannot inflict critical damage; both will prepare for a conflict requiring something to happen on American soil.────────────────────────────────────────[01:25:07]Hegseth Asks Congress for $1.5 Trillion for a War Trump Already Declared WonSenator to Hegseth: unlimited bomb money while cutting food, healthcare, and farm support; Palmer Luckey is building autonomous Terminator drones with Thiel's money.────────────────────────────────────────[01:52:30]The Covenant With Moses Was Conditional — Israel Broke It and God Destroyed the Nation ForeverPalestine today is a devilish counterfeit; the Old Testament testifies of Christ, not an ethnic group or political state — fundamental error of Christian Zionism.────────────────────────────────────────[01:55:08]Trump Contradicts Himself in the Same Sentence — Desperate to Meet Iran, But Not ReadyIran's missiles change speed mid-flight defeating every US defense system; Trump blamed Jordan attack on Jordanians. ──────────────────────────────────────── Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code “KNIGHT” For high quality made in America products go to HomeSteadProducts.shop and use promo code “Knight” for 10% off your purchases Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-show Or you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

What if the cancer diagnosis your doctor gave you is technically correct — but the treatment they chose has almost nothing to do with your actual cancer?This week, I sat down with Ed Clay, co-founder of TAM Center and Stem Cells, one of the world's most advanced translational medicine hospitals in Tijuana, Mexico. Ed started this journey the way most great things do — out of love. His mom got sick with no options in the US, so he bought a hospital and hired back the staff. She came in in a wheelchair and walked out.But what Ed has built since then? That's what blew my mind. His team — including the former chief of infectious disease at the NIH and the scientist who invented a test that reads 10,000 proteins at once — can sequence 20,000 of your cancer genes. Most US oncologists test 90.He dropped a bomb: there is not a single product on the market right now that can accurately detect cancer early through a blood test. Companies claiming otherwise? He's read their data. It's four patients.He also revealed why two people with the exact same cancer diagnosis can need completely different treatments — and why that distinction could be the difference between responding and not.This conversation will change how you think about what cancer actually is, and what it means to actually fight it.What we talk about:Why "ovarian cancer" in two different women can be two completely different diseases at the genetic levelThe lie behind liquid biopsy tests claiming to detect cancer in your bloodHow TAM goes from discovery to treating a patient in 6–12 months instead of 7 yearsA UFC champion's sister went from "weeks to live" to cancer-free in two months — here's what they foundZombie cells, senescence, and the peptide vaccine that could be the actual fountain of youthWhy combining genomics, proteomics, and methylation data could unlock cures for almost everythingCoffee enemas, Gerson therapy, and what happens to your body on day threeEpisode Links & Resources:Website: The Tam Center - https://thetamcenter.com | CPI Stem Cells - https://cellularperformanceinstitute.com/Podcast: https://www.edclayshow.com/Instagram: https://www.instagram.com/edclayofficialConnect with Tracy:Website: ⁠https://tracyduhs.com/⁠Hydration Shop: ⁠https://sanctuarysd.com/⁠Instagram: ⁠@tracyduhs⁠Flow FAM Community: ⁠https://tracyduhs.com/join-flow-fam/⁠

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss a case out of Australia—where an owner helped drive development of an mRNA vaccine for their dog's mast cell disease—that has sparked big questions in the exam room. In this episode, they unpack the implications for clinical practice, client expectations, and how veterinarians can navigate conversations around emerging, highly personalized therapies. Brought to you by Zoetis Resources: https://news.unsw.edu.au/en/meet-the-man-who-designed-a-cancer-vaccine-for-his-dog https://www.zoetisus.com/petcare/care-is-your-calling/ Contact: podcast@instinct.vet Where To Find Us: Website: CliniciansBrief.com/Podcasts YouTube: Youtube.com/@clinicians_brief Facebook: Facebook.com/CliniciansBrief LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ Instagram: @Clinicians.Brief X: @CliniciansBrief The Team: Alyssa Watson, DVM - Host Beth Molleson, DVM - Host Alexis Ussery - Producer & Multimedia Specialist Disclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

Headlines:  – Welcome To Mo News (02:00) – Iran Ceasefire Countdown As Latest Pakistan Talks Look Iffy (07:10) – Energy Secretary Says Gas Prices May Stay Above $3 A Gallon Until 2027 (14:00) – A Look At The Democrat-Israel Divorce (15:00) – Apple Names John Ternus CEO, Replacing Tim Cook, Who Becomes Chairman (26:50) – Trump Labor Secretary Resigns Amid Scandal (30:00) – FBI Director Sues The Atlantic For $250 Million Over Story On Alleged Excessive Drinking (33:00) – As Measles Takes Toll on Kids, Anti-Vaxxers Have Change of Heart (38:10) – Pancreatic Cancer mRNA Vaccine Shows Lasting Results In Early Trial (41:00) – Back To Back Boston Marathon Winners (43:00) – Humanoid Robot Wins Half-Marathon and Smashes Humans' Record (44:10) – On This Day In History (47:10) Thanks To Our Sponsors:  – ⁠Boll & Branch⁠ – 15% off first order, plus free shipping | Code: MONEWS –⁠ Industrious⁠ - Coworking office. 50% off day pass | Code: MONEWS50 – Incogni - 60% off an annual plan| Code: MONEWS – Monarch - 50% off your first year | Code: MONEWS – Factor - 50% off your first box | Code: monews50off – ShipStation - Try for free for 60 days | Code: MONEWS – Shopify – $1 per-month trial | Code: MONEWS – LMNT | Free Sample Pack with any LMNT drink mix or 12oz cans purchase – Aura Frames | $25 dollars off the Carver Mat frame | Code: MONEWS

The US military fires on and seizes an Iranian ship. Eight children were killed in the worst mass shooting in the country, since 2024.  President Trump announces an Oval Office Bible reading, amid a feud with the Pope. Promising new data from a pancreatic cancer vaccine trial. Plus, a hot air balloon makes an emergency landing in a backyard. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Intel's (INTC) recent rally isn't the only one investors should pay attention to, says Diane King Hall. She points to Moderna (MRNA) hitting a 52-week high after a trial drug to treat melanoma posted positive results. On the earnings front, Diane explains why investors are shaking off Procter & Gamble's (PG) mixed earnings and Abbott's (ABT) post-earnings sell-off. ======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about